October 1, 2024

October 2024 Provider Newsletter

Featured Articles

Digital SolutionsMedicare AdvantageOctober 1, 2024

Introducing the Care Provider Recognition Program from Anthem


Administrative

AdministrativeMedicaidOctober 16, 2024

External Independent Review (EIR) intake form

AdministrativeMedicare AdvantageMedicaidOctober 1, 2024

Drug and biologic

AdministrativeCommercialOctober 1, 2024

National Accounts 2025 precertification list

Digital SolutionsMedicare AdvantageOctober 1, 2024

Introducing the Care Provider Recognition Program from Anthem

Digital SolutionsCommercialMedicare AdvantageMedicaidAugust 30, 2024

Save time and get better results with optimized CPT code search in Availity Essentials

Digital SolutionsCommercialMedicare AdvantageMedicaidSeptember 4, 2024

Digital Provider Enrollment now available for additional provider types in Availity Essentials

Education & Training

Education & TrainingMedicare AdvantageSeptember 16, 2024

Seamless advance care: MyDirectives digital tool for D-SNP members

Policy Updates

Policy UpdatesMedicare AdvantageSeptember 3, 2024

Clinical Criteria updates

Policy UpdatesMedicaidSeptember 19, 2024

Clinical Criteria updates

Medical Policy & Clinical GuidelinesMedicaidAugust 27, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Medical Policy & Clinical GuidelinesMedicare AdvantageSeptember 10, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Prior AuthorizationMedicare AdvantageSeptember 23, 2024

Prior authorization requirement changes

Prior AuthorizationMedicaidSeptember 11, 2024

Prior authorization requirement changes

KYBCBS-CDCRCM-067867-24

AdministrativeMedicaidOctober 16, 2024

External Independent Review (EIR) intake form

Anthem has partnered with the Kentucky Department for Medicaid Services in order to create an External Independent Review (EIR) intake form. Providers will be required to use this form and submit to the MCO to request an external independent review effective October 1st. The form can be found at the following link: https://providernews.anthem.com/kentucky/files/5216

Using the Form:

    • Please use this form for all EIR requests. Verbal EIR requests will not be considered.
    • Written requests not on this form will not be considered.
  • If you would like to submit an EIR request, please use this form after you have exhausted the MCO’s internal appeal process.
  • An EIR must be submitted within 60 calendar days of the MCO final adverse determination. The 60 calendar day timeline begins with one of the following:
    • Date that the notice was received electronically, if received electronically;
    • Date that the notice was received via fax, per the date and time documented on the fax transmission, if the notice was faxed; or
    • Post mark date on the envelope containing the notice, if the notice was sent via postal mail. An additional three (3) days shall be added if the service is by mail.
    • Please do not use the claim EOB date to calculate timely filing
  • Any category on the form that is marked with an asterisk must be complete for the form to be considered.
  • Please be as specific as possible when stating your area of dispute or why you believe the MCO’s decision on appeal is erroneous. If you attach a document, please provide a specific explanation of its contents.
  • Please do not submit duplicate requests for EIR.

Types of Cases Eligible for EIR:

  • Service coverage requirements which include a claim involving:
    • Whether the given service is covered by the Medicaid program or
    • Whether the provider followed the MCO requirements for the covered service
  • Claim payment determination: Meaning cases stemming from the dollar amount paid on a claim or denial of a claim.
  • Medical necessity adverse benefit determination: Meaning a case stemming from an adverse medical necessity determination.

Types of Cases not Eligible for EIR:

The following submissions will not be considered.

  • Cases where the form is not filled out in its entirety
    • Please note incomplete forms may be resubmitted within the timely filing period.
  • Cases where MCO internal appeal rights have not been exhausted
  • Cases where the timely filing period has passed.
  • Claims that are part of a Special Investigations Unit (SIU) aka fraud, waste, or abuse investigation
  • Medicare claims or denials
  • Disputes based on reimbursement provisions or other provisions addressed in the proprietary agreement between the provider and the MCO

If you have any further questions, please reach out to your provider relations representative, or call provider services at 1-855-661-2028.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-067444-24-SRS67274

AdministrativeMedicare AdvantageMedicaidOctober 1, 2024

Drug and biologic

Effective December 1, 2024, Anthem is enhancing its claim edits system to ensure claims billed with pharmaceutical drug procedure codes are reported with the appropriate FDA-approved indicators for on- and off-label use.

These enhanced claim edits provide an opportunity for Anthem to evaluate submitted claims for drug quality, safety, and effectiveness. The enhancement is to have the claims deny if not billed with FDA indicator for on/off label use.

If you believe a claim reimbursement decision should be reviewed, please follow the normal claims dispute process outlined in the provider manual and include medical records that clarify whether the indication was approved through the governing agencies. You will need to submit only the portion(s) of the medical record that is relevant to the drug provided.

If you have questions about this notification, contact your contract manager or provider relationship management account representative.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CDCR-063018-24-CPN62565

AdministrativeCommercialOctober 1, 2024

National Accounts 2025 precertification list

The National Accounts 2025 Pre-certification List has been published. Please note, care providers should continue to verify member eligibility and benefits prior to rendering services.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-066138-24-SRS64578

ATTACHMENTS (available on web): National Accounts 2025 Pre-certification List (pdf - 1.52mb)

Digital SolutionsMedicare AdvantageOctober 1, 2024

Introducing the Care Provider Recognition Program from Anthem

Celebrating extraordinary impacts on health:

  • The new Care Provider Recognition Program honors excellence in Medicare patient care.
  • The annual program launching in the fall of 2024 will award top healthcare providers.
  • Winners will be chosen based on quality measures and good standing with health plans.

We’re committed to going beyond the contract to make a real impact on health together with our care providers. To celebrate and appreciate our care provider partners for outstanding performance in patient care, we’re excited to announce our new Care Provider Recognition Program.

This program honors successes and highlights those who are driving toward better outcomes. It provides care providers with an opportunity to thank and celebrate teams for going above and beyond to deliver high-quality, cost-efficient care, while driving health equity and exceptional patient experiences, and outcomes.

Launching in the fall of 2024, this annual program will recognize care providers who deliver excellence in care to their Medicare patients, our members — which makes it different from other distinctions in the industry. Winners of the 2024 Care Provider Recognition Award will be announced in mid-‑December. 

Winners will be selected based on the following criteria:

  • Top 5% of care providers based on quality measured through our internal Medicare data based on current performance and three-year average, including medical best practices such as preventive care screenings, immunizations, chronic disease management, and medication adherence
  • In-network and contract in good standing with an affiliated health plan

Driving toward better health outcomes is a critical shared goal with our care provider partners, and results like these are worthy of the spotlight.

We are committed to finding solutions that help our care provider partners offer quality services to our members.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066623-24-CPN65972

Digital SolutionsCommercialMedicare AdvantageMedicaidAugust 30, 2024

Save time and get better results with optimized CPT code search in Availity Essentials

Improvements in search capabilities in Availity Essentials now result in faster and more accurate results.

To help save you more time upfront while receiving more detailed eligibility and benefits information, we’ve expanded the Current Procedural Terminology® (CPT) code search capabilities in Availity Essentials’ Eligibility and Benefit tool.

These optimizations enable the use of up to eight specific CPT or Healthcare Common Procedure Coding System (HCPCS) codes per transaction for faster, more accurate, and personalized search results, which include:

  • Authorization requirement notifications — so you know up-front if an authorization is needed.
  • Additional plan-level benefit limitations details.
  • Cost-share information displayed by places of service and procedure codes.

Making these details available on the search results pages can help you save time and effort by giving you access to the right information you need when you need it. Additionally, it reduces the need to contact us, resulting in fewer calls and chats over time.

Watch the recorded training to see how you can start saving time today. Learning sessions show step-by-step how you can use the CPT code search capabilities in Availity Essentials to help increase your productivity. We're dedicated to supporting your success through digital solutions that help reduce your administrative burden and streamline your interactions with us.

If you have any questions, contact your provider relationship management representative.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CDCRCM-062265-24-CPN60904

Digital SolutionsCommercialMedicare AdvantageMedicaidSeptember 4, 2024

Digital Provider Enrollment now available for additional provider types in Availity Essentials

On September 23, 2024, Anthem will add new specialties to the Provider Enrollment tool hosted on Availity Essentials to further automate and improve your online enrollment experience.  

Who can use this new tool?

  • Therapy providers (physical therapist, occupational therapist, and speech therapist)
  • Audiologists and hearing aid fitter
  • Registered dieticians (independent providers should enroll through American Specialty Health (ASH) – go to https://ashcompanies.com/contact or call 800-972-4226)
  • Acupuncturists

What does the tool provide?

  • Add new providers to an already existing group.
  • Enroll as an individual provider.
  • Enroll a new group of providers.
  • Apply and request a contract. After review, a contract can be sent back to you digitally for an electronic signature. This eliminates the need for paper applications or paper contracts.
  • Use a dashboard for real-time status on the submitted applications.
  • Experience streamlined complete data submission.

Reviewing how the online enrollment application works

Availity Essentials’ online application will guide you throughout the enrollment process and provide status updates using a dashboard. As a result, you will know where each provider is in the application process without having to call or email for a status update.

Please note: For any changes to your practice profile, adding or deleting practitioners, and updating demographics, use the Provider Data Management (PDM) application on Availity Essentials that allows you to electronically submit any changes to your practice profile and demographics. Availity administrators and assistant administrators can access PDM by going to Availity > My Providers > Provider Data Management.

Accessing the Provider Enrollment application

Log on to Availity Essentials and select Payer Spaces > Anthem > Applications > Provider Enrollment to begin the enrollment process.

If your organization is not currently registered for Availity Essentials, the person in your organization designated as the Availity Essentials administrator should go to Availity.com and select Register.

For organizations already using Availity Essentials, your organization's Availity Essentials administrator should go to My Account Dashboard from the Availity home page to register new users and update or unlock accounts for existing users. Staff who need access to the Provider Enrollment tool need to be granted the role of Provider Enrollment. Availity administrators and user administrators will automatically be granted access to Provider Enrollment.

If you are using Availity Essentials today and need access to Provider Enrollment, please work with your organization’s administrator to update your Availity Essentials role. To determine who your administrator is, you can go to My Account Dashboard > My Administrators.

Need assistance with registering for Availity Essentials?

Contact Availity Client Services at 800-282-4548.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CDCRCM-059917-24-CPN59787

Education & TrainingMedicare AdvantageSeptember 16, 2024

Seamless advance care: MyDirectives digital tool for D-SNP members

At a glance:

  • Members enrolled in Dual Eligible Special Needs Plan (D-SNP) can have free access to MyDirectives to manage advance directives digitally.
  • Providers should discuss the importance of advance directives with patients during annual wellness visits.
  • Members can access MyDirectives through their member website to easily create, upload, and share advance directives.


Anthem is providing all Medicare Advantage members enrolled in a Dual Eligible Special Needs Plan (D-SNP) with free access to MyDirectives, an advance directives creation tool.

What is MyDirectives?

MyDirectives is a digital tool that can be used to easily create, maintain, and share information on advance directives. It has an easy-to-use guide that takes members through a series of questions about their care preferences, the establishment of healthcare agents (medical powers of attorney), the sharing of information, and more.

Your role as a provider

To support the successful delivery of person-centered care, providers should speak to their patients about the value of establishing an advance directive during the annual wellness visit. The CMS recently revised its advance care planning (ACP) fact sheet, which includes important documentation and time requirements for this service.

How members access and use MyDirectives

To get started with the Advance Directives program, members can visit the Anthem member website and select the Benefits tab to access the link for the Advance Directives program. Selecting this link will take the member to the MyDirectives app, where they can create a free account or link an existing account:

  • If they already have a written advance directive, MyDirectives allows members to upload copies of their current directives, making it easier to store and share when necessary.
  • Members can create a contact list of individuals who can have access to their advance directives, including physicians. A member’s advance directive can also be retrieved through national data exchanges such as eHealth Exchange, Carequality, and CommonWell Health Alliance.

MyDirectives customer support:

  • MyDirectives offers online customer support, which is the preferred contact method.
    Members can also call 888-884-3324 or email support@mydirectives.com.

We share a health vision with our care providers that means real change for consumers.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-068079-24

Policy UpdatesMedicare AdvantageSeptember 3, 2024

Clinical Criteria updates

Effective October 4, 2024

Summary: On June 10, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

October 4, 2024

*CC-0263

Imdelltra (tarlatamab-dlle)

New

October 4, 2024

*CC-0264

Anktiva (nogapendekin alfa inbekicept-pmln)

New

October 4, 2024

*CC-0265

Kisunla (donanemab)

New

October 4, 2024

*CC-0166

Trastuzumab Agents

Revised

October 4, 2024

CC-0187

Breyanzi (lisocabtagene maraleucel)

Revised

October 4, 2024

CC-0118

Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy (Azedra, Lutathera, Pluvicto, Zevalin)

Revised

October 4, 2024

CC-0094

Pemetrexed (Alimta, Pemfexy, Pemrydi)

Revised

October 4, 2024

CC-0032

Botulinum Toxin

Revised

October 4, 2024

*CC-0041

Complement C5 Inhibitors

Revised

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-063982-24-CPN63395

Policy UpdatesMedicaidSeptember 19, 2024

Clinical Criteria updates

Effective October 20, 2024

Summary: On June 10, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below apply only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that have been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective Date

Clinical Criteria Number

Clinical Criteria Title

New or Revised

October 20, 2024

*CC-0263

Imdelltra (tarlatamab-dlle)

New

October 20, 2024

*CC-0264

Anktiva (nogapendekin alfa inbekicept-pmln)

New

October 20, 2024

*CC-0265

Kisunla (donanemab)

New

October 20, 2024

*CC-0166

Trastuzumab Agents

Revised

October 20, 2024

CC-0187

Breyanzi (lisocabtagene maraleucel)

Revised

October 20, 2024

CC-0118

Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy (Azedra, Lutathera, Pluvicto, Zevalin)

Revised

October 20, 2024

CC-0094

Pemetrexed (Alimta, Pemfexy, Pemrydi)

Revised

October 20, 2024

CC-0032

Botulinum Toxin

Revised

October 20, 2024

*CC-0041

Complement C5 Inhibitors

Revised

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-066657-24-CPN65125

Medical Policy & Clinical GuidelinesMedicaidAugust 27, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Effective September 30, 2024

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter 1, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit Provider Medical Policies | Anthem.com.

Medical Policies

On February 15, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect September 30, 2024.

Publish date

Medical Policy number

Medical Policy title

New or revised

2/22/2024

MED.00140

Gene Therapy for Beta Thalassemia

Revised

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-062714-24-CPN62336

Medical Policy & Clinical GuidelinesMedicare AdvantageSeptember 10, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Effective October 10, 2024

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit https://anthem.com/provider/policies/clinical-guidelines.

Notes/updates

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive:

  • MED.00055 - Wearable Cardioverter Defibrillators:
    • Reformatted language from the to a wearable cardioverter defibrillator and moved punctuation
    • Added Not Medically Necessary statement when individual has an automated external defibrillator
  • RAD.00069 - Absolute Quantitation of Myocardial Blood Flow Measurement:
    • The use of absolute quantitation of myocardial blood flow testing is considered Investigational & Not Medically Necessary for all indications
  • SURG.00011 – Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting:
    • Revised ocular indications, including the addition of SurSight to Medically Necessary and Not Medically Necessary section and added new Medically Necessary criterion addressing non-healing or persistent corneal epithelial defects
    • Removed VersaWrap from Investigational & Not Medically Necessary statement
    • Removed Phasix Mesh from Investigational & Not Medically Necessary statement
    • Added Phasix Mesh and Phasix ST Mesh to Medically Necessary and Not Medically Necessary statements
  • CG-DME-54 - Mechanical Insufflation-Exsufflation Devices:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for use of mechanical insufflation-exsufflation devices

Medical Policies

On May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These Medical Policies take effect October 10, 2024.

Publish Date

Medical Policy Number

Medical Policy Title

New or Revised

6/28/2024

ANC.00009

Cosmetic and Reconstructive Services of the Trunk, Groin, and Extremities

Revised

6/28/2024

*MED.00055

Wearable Cardioverter Defibrillators

Revised

6/28/2024

*RAD.00069

Absolute Quantitation of Myocardial Blood Flow Measurement

New

6/28/2024

*SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Revised

6/28/2024

SURG.00121

Transcatheter Heart Valve Procedures

Revised

Clinical UM Guidelines

On May 9, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicare Advantage members on June 27, 2024. These guidelines take effect October 10, 2024.

Publish Date

Clinical UM Guideline Number

Clinical UM Guideline Title

New or Revised

6/28/2024

*CG-DME-54

Mechanical Insufflation-Exsufflation Devices

New

6/28/2024

CG-DME-55

Automated External Defibrillators for Home Use

New

6/28/2024

CG-MED-68

Therapeutic Apheresis

Revised

6/28/2024

CG-MED-97

Biofeedback and Neurofeedback

New

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066602-24-CPN65660

Prior AuthorizationMedicare AdvantageSeptember 23, 2024

Prior authorization requirement changes

Effective January 1, 2025

Effective January 1, 2025, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims.

Prior authorization requirements will be added for the following code(s):

Code

Description

0141U

Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected ePlex® BCID Gram-Positive Panel, GenMark Diagnostics, Inc, GenMark Diagnostics, Inc

0142U

Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected ePlex® BCID Gram-Negative Panel, GenMark Diagnostics, Inc, GenMark Diagnostics, Inc

0321U

Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique Bridge Urinary Tract Infection Detection and Resistance Test, Bridge Diagnostics

0369U

Infectious agent detection by nucleic acid (DNA and RNA), gastrointestinal pathogens, 31 bacterial, viral, and parasitic organisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique

0370U

GI assay (Gastrointestinal Pathogen with ABR), Lab Genomics LLC, Thermo Fisher Scientific

0373U

Infectious agent detection by nucleic acid (DNA and RNA), respiratory tract infection, 17 bacteria, 8 fungus, 13 virus, and 16 antibiotic-resistance genes, multiplex amplified probe technique, upper or lower respiratory specimen

0445U

β-amyloid (Abeta42) and phospho tau (181P) (pTau181), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology

0524T

Elecsys® PhosphoTau (181P) CSF (pTau181) and βAmyloid (1-42) CSF II (Abeta 42) Ratio, Roche Diagnostics Operations, Inc (US owner/operator)

21086

Impression & Custom Preparation; Auricular Prosthesis

36473

Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated

36482

Endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; first vein treated

64568

Open implantation of cranial nerve (eg, vagus nerve) neurostimulator electrode array and pulse generator

A2026

Restrata MiniMatrix, 5 mg

A4438

Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each

C1734

Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)

C9796

Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [SIS])

C9797

Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction

L5991

Addition to lower extremity prostheses, osseointegrated external prosthetic connector

L8045

Auricular Prosthesis

Q4305

American Amnion AC Tri-Layer, per sq cm

Q4306

American Amnion AC, per sq cm

Q4307

American Amnion, per sq cm

Q4308

Sanopellis, per sq cm

Q4309

VIA Matrix, per sq cm

S9002

Intravaginal motion sensor system, provides biofeedback for pelvic floor muscle rehabilitation device

Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://anthem.com/provider/medicare-advantage on the Resources tab or for contracted providers by accessing Availity.com.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066981-24-CPN66375

Prior AuthorizationMedicaidSeptember 11, 2024

Prior authorization requirement changes

Effective November 1, 2024

Effective November 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicaid members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims.

Prior authorization requirements will be added for the following code(s):

Code

Description

33263

Removal Of Pacing Cardioverter-Defibrillator Pulse Generator With Replacement Of Pacing Cardioverter-Defibrillator Pulse Generator; Dual Lead System

64582

Open implantation of hypoglossal nerve neurostimulator array, pulse generator, and distal respiratory sensor electrode or electrode array

To request PA, you may use one of the following methods:

  • Web: once logged in at Availity.com.
  • Fax: 800-964-3627
  • Phone: 855-661-2028

Not all PA requirements are listed here. Detailed PA requirements are available to providers on providers.anthem.com/ky on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at 855-661-2028 for assistance with PA requirements.

UM AROW A2024M1414

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-059306-24-CPN58059

Reimbursement PoliciesCommercialOctober 1, 2024

Reimbursement policy update: Modifiers 59 and XE, XP, XS, and XU: Distinct Procedural Service — Professional

Beginning with dates of service on or after January 1, 2025, Anthem will update the Modifiers 59 and XE, XP, XS, and XU: Distinct Procedural Service — Professional reimbursement policy Related Coding section to add the following:

  • J1202 will deny when reported with G0138.

In addition, the policy title was renamed from Distinct Procedural Service: Modifiers 59 and XE, XP, XS, and XU.

For specific policy details, visit the reimbursement policy page.

We are committed to finding solutions that help our care provider partners offer quality services to our members.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-067539-24

Reimbursement PoliciesMedicare AdvantageOctober 1, 2024

Clarification to reimbursement policy update: Nurse Practitioner and Physician Assistant Services

(Policy G-20002, effective 11/01/2024)

In the August 2024 edition of the Provider News, we announced an update to the Nurse Practitioner and Physician Assistant Services policy. To clarify, we are aligning the reimbursement policy with Centers for Medicare & Medicaid Services (CMS) guidelines to indicate which services will be eligible for a payment reduction according to the Nurse Practitioner and Physician Assistant Services reimbursement structure.

The following services are subject to the Nurse Practitioner and Physician Assistant Services reimbursement payment reduction and will be removed from the physicians’ services exclusion section:

    • Preventive Services
    • Radiology Services

The following services are not subject to the NP PA reimbursement payment reduction and will be included in the physicians’ services exclusion section:

    • Durable Medical Equipment Prosthetics, Orthotics, and Supplies (DMEPOS)
    • Laboratory Services and Screening Services

For specific policy details visit the reimbursement policy page.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066719-24-CPN66373

Products & ProgramsCommercialOctober 1, 2024

Introduction of the Specialty High Performing Provider designation program for commercial networks

In a previous newsletter, Anthem informed you that we were implementing a new High Performing Provider (HPP) designation to care providers meeting certain cost and quality metrics as part of our expansion of consumer tools and programs. In that communication, we indicated that the designation will initially focus on certain types of professional providers we categorize as primary care providers (PCPs), but it may be broadened to include other care provider types in the future.

Effective on or about December 1, 2024, Anthem will use a new HPP methodology (cost and quality metrics) to designate certain specialists as High Performing Providers.

The methodology we notified you about in the newsletter article (where a link to the methodology was included) will continue to be used for the designation of PCPs. That methodology has been revised to apply to specialists.

As with PCP HPP, Anthem may highlight specialist HPPs in various ways, including, but not limited to:

  • Special opportunities to participate in product offerings.
  • When members contact Anthem with requests for referral options.
  • Placing a designation in the Care and Cost Finder. This would be in addition to Anthem’s existing tool in Care and Cost Finder called Personalized Match, which provides Anthem members with the option to search for in-network care providers through a specialized sorting tool that considers certain cost and quality metrics as well.
  • Personalized Match search results sorting similar to how the HPP methodology for non-Exchange PCPs impacts Personalized Match rankings. You may review a copy of the Personalized Match methodology for Exchange PCPs posted on Availity Essentials — our secure web-based provider tool — using the following navigation: Go to Availity > Payer Spaces > Health Plan > Provider Online Reporting > Programs > Personalized Match Methodology.pdf.

As shown in the specialty HPP methodology, the specialty methodology for determining a specialty HPP closely mirrors the methodology for determining an HPP PCP.

To view the specialty HPP designation methodology which includes a listing of specialties included, please click here. For more information on the specialty HPP designation, or to find out if your practice will receive the specialty HPP designation, please contact Provider Services or your local provider relationship management representative.

Look for further updates on the specialty HPP designation in this newsletter. To sign up for this newsletter, go to https://providernews.anthem.com, select the appropriate state, and then select Subscribe to Email in the top right corner.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-065488-24-CPN65370

ATTACHMENTS (available on web): High Performing Provider (HPP) 1.0 Methodology Summary Specialty Care Providers Commercial (pdf - 1.94mb)

Products & ProgramsCommercialOctober 1, 2024

Introduction of the HPP designation program for individual member (Exchange) commercial networks

Anthem informed you in a previous newsletter that we were implementing a new High Performing Provider (HPP) designation to care providers meeting certain cost and quality metrics as part of our expansion of consumer tools and programs. We informed you that initially the designation will focus on certain types of professional providers we categorize as primary care providers (PCPs), but it may be broadened to include other care provider types in the future.

Beginning October 31, 2024, Anthem will be using a new HPP methodology (cost and quality metrics) to designate HPPs for PCPs participating in our individual member (Exchange) plan networks that service our Affordable Care Act plans (IND HPPs). The new IND HPP methodology will be tailored for our Exchange plans.

The methodology we notified you about in the newsletter article (where a link to the methodology was included) will continue to be used for our non-Exchange commercial health plan networks.

As with the non-Exchange HPP designation, Anthem may highlight Exchange HPPs in various ways, including, but not limited to:

  • Offering special opportunities to participate in product offerings.
  • When members contact Anthem with requests for referral options.
  • Placing a designation in the Care and Cost Finder. This would be in addition to Anthem’s existing tool in Care and Cost Finder, called Personalized Match, which provides Anthem members with the option to search for in-network care providers through a specialized sorting tool that considers certain cost and quality metrics as well.
  • Personalized Match search results sorting, similar to how the HPP methodology for non-Exchange PCPs impacts Personalized Match rankings. You may review a copy of the Personalized Match methodology for Exchange PCPs posted on Availity – our secure web-based provider tool – using the following navigation: Go to Availity > Payer Spaces > Health Plan > Provider Online Reporting > Programs > Personalized Match Methodology.pdf.
  • A factor in auto assignment PCP methodology for health benefit plans that require a member to pick a PCP and the member fails to do so.

The IND HPP methodology for determining an IND HPP is similar to the methodology for determining an HPP PCP in general (which services the health plan’s large and small group commercial populations); however, certain metrics may solely apply to the individual member population. The IND HPP designation is solely for PCPs seeing an individual member population and is not for specialists.

You can view the IND HPP designation methodology here. For more information on the individual HPP designation, or to know if your practice will receive the individual HPP designation, please contact Provider Services or your local provider relationship management representative.  

Look for further updates on the IND HPP designation in this newsletter. To sign up for this newsletter, go to https://providernews.anthem.com, select the appropriate state, and then select Subscribe to Email in the top right corner.


Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-062857-24-CPN60903

ATTACHMENTS (available on web): Individual Member (Exchange) High Performing Provider designation (pdf - 1.01mb)

PharmacyCommercialSeptember 16, 2024

Specialty pharmacy updates — October 2024

The specialty pharmacy updates for Anthem are listed below.

Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc.

Note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request a prior authorization review for your patients’ continued use of these medications.

The inclusion of a National Drug Code (NDC) code on your claim will help expedite the claim processing of drugs billed with a Not Otherwise Classified (NOC) code.

Prior authorization updates

Effective for dates of service on or after January 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process.

Access our Clinical Criteria at https://tinyurl.com/4dv6rxe4 to view the complete information for these prior authorization updates.

Clinical Criteria

Drug

HCPCS or CPT® code(s)

CC-0265

Kisunla (donanemab)

J0175

CC-0041

Piasky (crovalimab-akkz)

J3590

Step therapy updates

Effective for dates of service on or after January 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process.

The current Orencia step therapy preferred product list under the medical benefit is being modified to include only those that are considered medical benefit drugs.

Access our Clinical Criteria at https://tinyurl.com/4dv6rxe4 to view the complete information for these step therapy updates.

Clinical Criteria

Status

Drug

HCPCS or CPT code(s)

CC-0078

Non-Preferred

Orencia

J0129

CC-0078

Preferred

Avsola

Q5121

CC-0078

Preferred

Remicade

J1745

CC-0078

Preferred

Unbranded Infliximab

J1745

CC-0078

Preferred

Simponi Aria

J1602

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Quantity limit updates

Effective for dates of service on or after January 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process.

Access our Clinical Criteria at https://tinyurl.com/4dv6rxe4 to view the complete information for these quantity limit updates.

Clinical Criteria

Drug

HCPCS or CPT code(s)

CC-0265

Kisunla (donanemab)

J0175

CC-0041

Piasky (crovalimab-akkz)

J3590

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-067804-24-CPN67634

PharmacyMedicaidSeptember 19, 2024

Prior authorization updates for medications billed under the medical benefit

Effective on or after November 1, 2024, the following medication codes will require prior authorization.

Please note that the inclusion of a National Drug Code (NDC) on your medical claim is necessary for claims processing.

Visit the Clinical Criteria website to search for the specific Clinical Criteria listed below.

Clinical Criteria

HCPCS or CPT® code(s)

Drug name

CC-0259

J3490, J3590

Amtagvi (lifleucel)

CC-0258

J3490, J3590

iDoseTR (travoprost Implant)

CC-0260

J7353

Nexobrid (anacaulase-bcdb)

What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local provider relationship management representative or call Provider Services at 855-661-2028.

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-065618-24-CPN64071

PharmacyMedicaidSeptember 19, 2024

Prior authorization updates for medications billed under the medical benefit

Effective for dates of service on or after November 1, 2024, the following medication codes will require prior authorization.

Please note that the inclusion of a National Drug Code (NDC) on your medical claim is necessary for claims processing.

Visit the Clinical Criteria website to search for the specific Clinical Criteria listed below.

Clinical Criteria

HCPCS or CPT® code(s)

Drug name

CC-0003

J1599

Alyglo (immune globulin intravenous,
human-stwk)

CC-0062

J3590

Simlandi (adalimumab-ryvk)

CC-0261

C9399, J3590

Winrevair (sotatercept-csrk)

What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local provider relationship management representative or call Provider Services at 855-661-2028.

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-065385-24-CPN64077

PharmacyMedicare AdvantageOctober 1, 2024

Medicare Part D overhaul: What's new in 2025 for your prescription drug costs?

At a glance:

  • Significant Medicare Part D updates in 2025 include a $2,000 out-of-pocket cap and elimination of the coverage gap.
  • Enhanced benefits will remove cost-sharing in catastrophic coverage and expand low-income subsidies to 150% of the federal poverty level (FPL).
  • The Medicare Prescription Payment Plan (M3P) will allow members to spread out prescription costs over the year for added financial flexibility.

What's changing in 2025?

Changes in deductible and out-of-pocket thresholds

In 2024, the standard deductible was $545 with the initial coverage limit at $5,030, and the catastrophic coverage threshold was $8,000. By 2025, the deductible will increase to $590, and members will enter the catastrophic phase when their out-of-pocket expenditure reaches $2,000. Members might see higher upfront costs due to the increased deductible, but reaching catastrophic coverage will be significantly easier, offering greater financial protections much sooner.

Elimination of the coverage gap (donut hole)

The elimination of the coverage gap will simplify the benefit structure. Previously, beneficiaries paid 25% of the cost of both brand-name and generic drugs in the coverage gap. The full elimination of this gap will remove the phase where members faced higher out-of-pocket costs, reducing financial uncertainty and streamlining the benefits process.

Introduction of a $2,000 out-of-pocket cap

In 2025, after reaching the $2,000 out-of-pocket cap, members will no longer have to pay added costs for their medications for the remainder of the year. This offers financial protection and predictability in managing healthcare expenses, helping those with high prescription drug costs.

Elimination of cost-sharing in catastrophic coverage

While in 2024, members had to pay 5% of drug costs after reaching the out-of-pocket threshold; this requirement will lift entirely in the next year. This ensures complete coverage once members reach the catastrophic phase, removing the financial burden for members with extremely high drug costs.

Enhanced low-income subsidy (LIS) benefits

We are also introducing enhanced LIS benefits, extending full benefits to individuals with incomes up to 150% of the FPL from the previous 135% FPL threshold. This change means more members will qualify for full LIS benefits, reducing their premiums, deductibles, and copayments, which improves access to necessary medications for low-income beneficiaries.

Introduction of the Medicare Prescription Payment Plan (M3P)

M3P allows members to manage their out-of-pocket Medicare Part D drug costs by spreading the total sum of their filled prescription costs across the calendar year. This option is voluntary, free to enroll, and members can choose to participate at any point during the year. Instead of paying at the pharmacy, members will receive a bill from their health or drug plan to pay for their prescription drugs each month, offering greater financial flexibility and predictability.

Action plan and resources

To ensure a smooth transition, we’ve laid out a comprehensive educational and communication strategy:

  • Information campaign: As of July 2024, we began an extensive marketing and educational campaign, including public relations efforts, direct member communications, and care provider briefings.
  • Training and support: We are providing training materials, talking points, and FAQs to our support teams, ensuring they are well-prepared to assist you.

Key dates:

  • October 15, 2024: Enrollment in M3P begins
  • January 1, 2025: All other M3P requirements become effective

Next steps:

  • Care providers should stay up to date and make use of the resources we provide to better assist patients. Staying updated on any changes in the formulary and benefit structures will ensure that you can provide the highest quality care possible.
  • Members should keep an eye out for detailed communications about their enhanced Medicare Part D coverage. Members can contact our support team for personalized assistance.

Contact us

Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to Availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.

For additional support, visit the Contact Us section of our provider website for the appropriate contact.

As we move into 2025, our goal is to provide you with the knowledge and resources needed to maximize the new Medicare Part D benefits. Thank you for trusting us to help manage your healthcare needs.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-067660-24-CPN65205

PharmacyCommercialOctober 1, 2024

Pharmacy information available on our provider website

Visit the Drug Lists page on our website at anthem.com/ms/pharmacyinformation/home.html for more information about:

  • Copayment/coinsurance requirements and their applicable drug classes.
  • Drug lists and changes.
  • Prior authorization criteria.
  • Procedures for generic substitution.
  • Therapeutic interchange.
  • Step therapy or other management methods subject to prescribing decisions.
  • Any other requirements, restrictions, or limitations that apply to using certain drugs.

The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

To locate the exchange, select Formulary and Pharmacy Information and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits.

Please call provider services to request a copy of the pharmaceutical information available online if you do not have internet access.

Through our efforts, we are committed to reducing administrative burden because we value you, our care provider partner.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-068346-24